PCSK9 siRNA, on top of maximally tolerated statin therapy, potently lowers LDL-c3' education - Nov. 16, 2019 - R. Scott Wright, MD, Rochester, MN, USA - AHA 2019, Philadelphia
This video was recorded at the AHA in Philadelphia, USA, on november 16, 2019.
R. Scott Wright, MD, is cardiologist at the Mayo Clinic in Rochester, USA.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.